Financials
Financial year 2025
Gross margin
€ 859,250
▼ 5% vs 2024
Profit
Caution€ -57,094
▼ 317% vs 2024
Debts
High€ 934,492
▲ 41% vs 2024
MEDISCH CENTRUM GENK from Genk, company number BE0431775110, closed financial year 2025 with a result of € -57,094 after tax. For that financial year MEDISCH CENTRUM GENK recorded a gross margin of € 859,250 and equity of € 70,679. Compared with financial year 2024, the result moved from € 26,305 to € -57,094. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
What happened at MEDISCH CENTRUM GENK?
What happened at MEDISCH CENTRUM GENK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dokters Gevers BV stepped down as director. NBB
- Boelhouwers Reumatologie BV stepped down as director. NBB
- Dr. Joris Heyligen, Reumatologie BV stepped down as director. NBB
- Dr. Heleen Cypers, Reumatologie BV stepped down as director. NBB
- Dr. Van den Bossche Bert, Reumatoloog BV stepped down as director. NBB
- Dr. I. Gofita Reumatoloog BV stepped down as director. NBB
- Dr. Marc Piessens BV stepped down as director. NBB
- Dr. PH. De Vusser BV stepped down as director. NBB
In short
From € 68,207 profit in 2021 to € 57,094 loss in 2025.
Paid € 17,117 in corporate taxes since 2021.
Best year ever: 2021, with € 68,207 profit.
On average € 68,700 of value added per employee in 2025.
A new publication or filing at MEDISCH CENTRUM GENK? We notify you, reason included.
Follow MEDISCH CENTRUM GENKNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Dr. Heleen Cypers, Reumatologie BV
Director · represented by Heleen Cypers
since 2022 · until 2028
Director · represented by Kristof Thevissen
since 2020 · until 2026
Dr. Joris Heyligen, Reumatologie BV
Director · represented by Joris Heyligen
since 2023 · until 2029
Director · represented by Spyridon Kefalas
since 2020 · until 2026
Director · represented by Marc Piessens
since 2021 · until 2027
Director · represented by Philip Remans
since 2020 · until 2026
Director · represented by Anna-Maria Gevers
since 2023 · until 2029
Director · represented by Patrick Jorissen
since 2020 · until 2026
Dr. Van den Bossche Bert, Reumatoloog BV
Director · represented by Bert Van Den Bossche
since 2022 · until 2028
Director · represented by Christoph Bambynek
since 2020 · until 2026
Director · represented by Philip De Vusser
since 2021 · until 2027
Jan Remans
Director
since 2020 · until 2026
Director · represented by Ioana Gofita
since 2022 · until 2028
Director · represented by Fleur Boelhouwers
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Weg naar As 123
3600 Genk
Weg naar As 100
3600 Genk
Active since 1 October 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0431.775.110
- VAT number
- BE 0431.775.110
- Registered office
- Weg naar As 123, 3600 Genk
- Names & denominations
- MEDISCH CENTRUM GENK · M.C.G.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 August 1987
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken